Faeth Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2020 | $-6.5M | $-6.5M | $52.0K | $194.0K |
| Jun 2020 | $-2.8M | $-2.8M | $2.0K | $163.0K |
| Sep 2020 | $-5.8M | $-6.6M | $836.0K | $781.0K |
| Dec 2020 | $-2.7M | $-3.0M | $316.0K | $354.0K |
| Mar 2021 | $-10.8M | $-11.3M | $487.0K | $1.3M |
| Jun 2021 | $-6.0M | $-6.7M | $616.0K | $1.7M |
| Sep 2021 | $-5.6M | $-6.0M | $388.0K | $1.7M |
| Dec 2021 | $-7.9M | $-8.4M | $535.0K | $826.0K |
| Mar 2022 | $-10.8M | $-10.8M | $19.0K | $1.5M |
| Jun 2022 | $-11.9M | $-12.0M | $52.0K | $1.4M |
| Sep 2022 | $-6.8M | $-7.1M | $250.0K | $1.5M |
| Dec 2022 | $-9.6M | $-9.6M | $0 | $1.4M |
| Mar 2023 | $-11.7M | $-11.9M | $151.0K | $1.2M |
| Jun 2023 | $-9.5M | $-9.5M | $29.0K | $1.1M |
| Sep 2023 | $-4.7M | $-4.7M | $0 | $1.0M |
| Dec 2023 | $-6.2M | $-6.2M | $0 | $1.1M |
| Mar 2024 | $-7.6M | $-7.7M | $37.0K | $1.2M |
| Jun 2024 | $-5.8M | $-5.9M | $109.0K | $795.0K |
| Sep 2024 | $-5.5M | $-5.5M | $0 | $733.0K |
| Dec 2024 | $-5.8M | $-5.8M | $0 | $391.0K |
| Mar 2025 | $-7.1M | $-7.1M | $0 | $461.0K |
| Jun 2025 | $-5.9M | $-5.9M | $16.0K | $264.0K |
| Sep 2025 | $-3.6M | $-3.6M | $0 | $254.0K |
| Dec 2025 | $-3.9M | $-3.9M | $0 | $295.0K |
| Mar 2026 | $-10.7M | $-10.7M | $6.0K | $12.9M |
| Jun 2026 | $-15.7M | $-15.7M | $0 | $4.5M |